The eCoin system, approved by the united state Food and Drug Administration in March 2022 for the treatment of necessity urinary system incontinence, is based upon tibial nerve excitement. The tibial nerve is associated with movement and sensation in the legs and feet, and it additionally influences the nerves that control the bladder.